Abstract:Poor drug delivery to solid tumors remains a great challenge for effective antitumor therapy. Herein, multistage stimuli-responsive nanovectors based on hollow mesoporous silica nanoparticles (HMSNs) were prepared to avoid delivery barriers for improved penetration and programmed tumor therapy. The versatile nanosystem was constructed through electrostatic complexation between the functional HMSNs loaded with gemcitabine (GEM) and the small-sized platinum prodrug-conjugated poly(amidoamine) dendrimer (PAMAM-Pt). The HMSNs were functionalized with dimethylmaleic anhydride tethered chitosan oligosaccharide to endow the particles of HMSN-CS(DMA) with charge-reversal properties. The as-prepared nanosystem had a stable structure of size ∼130 nm at pH 7.4, which is beneficial for blood circulation and tumor vessel extravasation of nanocarriers. Once it reaches the tumor site, the nanosystem can dissociate into HMSN@GEM-CS (∼120 nm) and PAMAM-Pt dendrimer nanocarriers (∼5 nm) in response to the acidic tumor microenvironment because of the acid-mediated charge-reversal, then the HMSN@GEM can play the antitumor role in surface tumor tissues. The dissociated PAMAM-Pt showed excellent performance in tumor penetration, cell uptake and intracellular trafficking due to the small size and positive charge, which was supported by the study of three-dimensional multicellular spheroids in vitro. Finally, the active cisplatin was released from the PAMAM-Pt dendrimer under the intracellular reducing environment to kill cells in deep tumor tissues. The significant tumor suppression of this system in vivo was validated in the A549 tumor xenografted mouse model. Such a stimuli-responsive nanosystem that integrates simple preparation, biocompatibility, biodegradability and programmed tumor therapy manifests great potential for clinical trials.

Virus-mimicking Mesoporous Organosilica Nanocapsules with Soft Framework and Rough Surface for Enhanced Cellular Uptake and Tumor Penetration

In Situ Protein-Templated Porous Protein-Hydroxylapatite Nanocomposite Microspheres for Ph-Dependent Sustained Anticancer Drug Release

Virus-Bionic Mesoporous Silica Nanoplatform for Malignant Tumor Inhibition via Effective Cellular Uptake and Precise Drug Delivery

Virus-like hollow mesoporous silica nanoparticles for cancer combination therapy

Biomimetic virus-like mesoporous silica nanoparticles improved cellular internalization for co-delivery of antigen and agonist to enhance Tumor immunotherapy

Camouflaged Virus-Like-Nanocarrier with a Transformable Rough Surface for Boosting Drug Delivery

Dynamic-responsive Virus-Mimetic Nanocapsules Facilitate Protein Drug Penetration and Extracellular-Specific Unpacking for Antitumor Treatment

Deformable Double-Shelled Hollow Mesoporous Organosilica Nanocapsules: A Multi-Interfacial Etching Strategy

Morphological and Constituent Viral-Mimicking Self-Assembled Nanoparticles Promote Cellular Uptake and Improve Cancer Therapeutic Efficiency in Vivo

Facile Synthesis of Uniform Virus-like Mesoporous Silica Nanoparticles for Enhanced Cellular Internalization

Nanocapsules: Macrophage Cell Membrane Camouflaged Mesoporous Silica Nanocapsules for In Vivo Cancer Therapy (Adv. Healthcare Mater. 11/2015)

Dual-modal overcoming of physical barriers for improved photodynamic cancer therapy via soft organosilica nanocapsules

Hierarchically Stimuli-Responsive Nanovectors for Improved Tumor Penetration and Programed Tumor Therapy

Viral Capsids Mimicking Based on Ph-Sensitive Biodegradable Polymeric Micelles for Efficient Anticancer Drug Delivery.

Nanoparticles exhibiting virus-mimic surface topology for enhanced oral delivery

Carrier-free Nanodrug-Based Virus-Surface-mimicking Nanosystems for Efficient Drug/gene Co-Delivery.

Deformable Hollow Periodic Mesoporous Organosilica Nanocapsules for Significantly Improved Cellular Uptake.

Molecularly Organic/inorganic Hybrid Hollow Mesoporous Organosilica Nanocapsules with Tumor-Specific Biodegradability and Enhanced Chemotherapeutic Functionality

Multiple-Responsive Mesoporous Silica Nanoparticles for Highly Accurate Drugs Delivery to Tumor Cells

Membrane-cloaked polydopamine modified mesoporous silica nanoparticles for cancer therapy

Biphasic synthesis of biodegradable urchin-like mesoporous organosilica nanoparticles for enhanced cellular internalization and precision cascaded therapy